ANZCTR - Registration

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers

Trial registered on ANZCTR

Registration number

ACTRN12619001717145

Ethics application status

Approved

Date submitted

23/10/2019

Date registered

5/12/2019

Date last updated

11/12/2019

Date data sharing statement initially provided

5/12/2019

Type of registration

Prospectively registered

Titles & IDs

Public title

Study of the effectiveness of conventional physiotherapy treatment supplemented with a protocol for strengthening the gluteus maximus in patients with femoral patellar syndrome.

Scientific title

Study of the effectiveness of gluteus maximus strengthening in femoro-patellar syndrome. Randomized clinical trial.

Secondary ID [1]

Nill known

Universal Trial Number (UTN)

U1111-1241-7686

Trial acronym

Linked study record

Health condition

Health condition(s) or problem(s) studied:

Femoro-patellar syndrome.

Condition category

Condition code

Musculoskeletal

Other muscular and skeletal disorders

Physical Medicine / Rehabilitation

Physiotherapy

Intervention/exposure

Study type

Interventional

Description of intervention(s) / exposure

Study of the effectiveness of gluteus maximus strengthening in femoro-patellar syndrome.

The sample (74 subjects) is randomly divided into two groups. In both groups, a physiotherapeutic treatment based on masotherapy, patella mobilizations, isometric quadriceps exercises, and Transcutaneous electrical nerve stimulation (TENS) will be carried out. Compex 3.0 ® will be used by applying the “smart TENS” analgesic function. The impulse form is biphasic and pulsed, the frequency is 80Hz, the amplitude is 125 msec and finally, the intensity depends on the patient, because each of them has a different pain tolerance. The sessions will be carried out every 2 weeks, and in each of them the TENS will be applied for 15 minutes. In group 2 or intervention, you will also add some home exercises to strengthen the gluteus maximus.

It will work with five variables, obtained by different tests: Y-Balance Test, Triple single-leg jump, Q angle measurement, measurement of gluteus maximus strength using a dynamometer, and questionnaire "Kujala Knee Pain".

The study will be carried out by both of the physiotherapists in charge of the study. One of them will be responsible for making the measurements to be evaluated unaware of neither which group each subject belongs to, nor the results obtained in previous measurements; while the other physiotherapist will carry out the measurement of the gluteus maximus as well as the treatments, aware of which group each subject belongs to.

Measurements of the different variables will be made once every 3 months. Treatment sessions will be every two weeks, each one of them lasting approximately 30 minutes. The whole study will be undergone in two physiotherapy clinics in Vigo, Spain.

The intensity of the protocol will be hard (6 -7 Borg RPE Scale) and the total duration of the intervention will be 6 months. The frecuency of the sessions at home will be 10 minute sessions a day, 4 days a week. Also, the physiotherapist will send a reminder via text message to ensure that all patients complete the exercises.

The gluteus maximus protocol exercises will be "Buttock Bridge", "walk sideways with miniband", "Hip extension with 90º knee flexion from standing with the ventral aspect of the trunk resting on the stretcher", "External hip rotation from quadruped" and "Clam".

Intervention code [1]

Rehabilitation

Intervention code [2]

Treatment: Other

Comparator / control treatment

- Treatment will be started by doing therapeutic massage on the quadriceps, since it has been demonstrated that the relaxation of the musculature involved has a very important role in the treatment of femoropatelar syndrome. This technique will last approximately 15 minutes.
- Exercises of quadriceps contraction will be included, during which both the intensity as well as the repetition number will be tailor made to each patient. After the third month, this exercise will be complemented with electrostimulation of the medial vastus. This technique will be used because it has been demonstrated that it helps improve the patella mobilization.
- TENS will be used as an analgesic technique. TENS will be applied for 15 minutes on an intensity in which the patient does not feel pain.
- Lastly, the McConnell taping technique will be used in order to attempt to correct the patella anormal position.

Control group

Active

Outcomes

Primary outcome [1]

Measurement of the gluteus maximus strength by dynamometer.

Timepoint [1]

Timepoint: baseline, 3 months (primary timepoint) and 6 months after intervention commencement.

Secondary outcome [1]

Measurement of knee pain using the "Kujala Knee Pain" questionnaire.

Timepoint [1]

Timepoint: baseline, 3 months and 6 months after intervention commencement.

Eligibility

Key inclusion criteria

- People between 18 and 65 years old.
- People with femoropatellar syndrome of at least 6 months, diagnosed by a specialist doctor.
- People who understand and are able to do the protocol exercises correctly.
- People who have enough commitment to do the exercises proposed during the study.
- People who are able to maintain standing or walking completely autonomously.

Minimum age

18 Years

Maximum age

65 Years

Sex

Both males and females

Can healthy volunteers participate?

Key exclusion criteria

- People with hip and / or ankle pathology.
- People with a cardiac pathology which has been diagnosed either at the beginning of the study or as during it.
- People who are pregnant.
- People who have undergone surgery or knee infiltration.
- People who show strong knee mobility limitations.
- People who are currently undergoing rehabilitation related to knee pain.

Study design

Purpose of the study

Treatment

Allocation to intervention

Randomised controlled trial

Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)

A computer program is used to randomize both groups.

Methods used to generate the sequence in which subjects will be randomised (sequence generation)

Simple randomisation using a randomisation table created by computer software.

Masking / blinding

Blinded (masking used)

Who is / are masked / blinded?

The people analysing the results/data

Intervention assignment

Parallel

Other design features

The sample is divided into two groups:
1. Conventional treatment.
2. Conventional treatment + exercise protocol.

Phase

Not Applicable

Type of endpoint/s

Efficacy

Statistical methods / analysis

To carry out this study, a sample size of 74 subjects (37 in each group) will be considered. This value has been calculated using the GPower 3.1.9.4 ® assuming an error of 0.05, with a study power of 80% and an effect size of 0.69 obtained from a previous reference study. Hence, by using this program, a sample of 68 subjects is estimated, which will extend up to 74 to take into account a 10% margin due to the possible losses that may take place.

Recruitment

Recruitment status

Not yet recruiting

Date of first participant enrolment

Anticipated

16/12/2019

Actual

Date of last participant enrolment

Anticipated

7/01/2020

Actual

Date of last data collection

Anticipated

9/07/2020

Actual

Sample size

Target

Accrual to date

Final

Recruitment outside Australia

Country [1]

Spain

State/province [1]

Galicia

Funding & Sponsors

Funding source category [1]

Self funded/Unfunded

Name [1]

There aren’t any sponsor or external funding.

Address [1]

There aren’t any sponsor or external funding.

Country [1]

Primary sponsor type

University

Name

University of Alcala de Henares

Address

Av. de León, 3A, 28805 Alcalá de Henares, Madrid

Country

Spain

Secondary sponsor category [1]

None

Name [1]

Address [1]

Country [1]

Ethics approval

Ethics application status

Approved

Ethics committee name [1]

Comité de Ética de la Investigación y Experimentación Animal de la Universidad de Álcala de Henares

Ethics committee address [1]

Colegio de León c/ Libreros, 21 28801 Alcalá de Henares (Madrid)

Ethics committee country [1]

Spain

Date submitted for ethics approval [1]

Approval date [1]

05/09/2019

Ethics approval number [1]

CEIM/HU/201920

Summary

Brief summary

The hypothesis is that an increase in gluteus maximus strength is a protective factor of the femoropatelar syndrome, that is to say, the symptomatology of the femoropatellar syndrome decreases when the strength of the gluteus maximus is higher.

The main objective is to verify the effectiveness of a gluteus maximization strengthening protocol as a treatment of femoral patellar syndrome.

Trial website

Trial related presentations / publications

Public notes

Contacts

Principal investigator

Name

Miss Cristina Ruano Jiménez

Address

University of Alcala de Henares.
Av. de León, 3A, 28805 Alcalá de Henares, Madrid

Country

Spain

Phone

+34 691524139

Fax

crisruano95@gmail.com

Contact person for public queries

Name

Cristina Ruano Jiménez

Address

University of Alcala de Henares
Av. de León, 3A, 28805 Alcalá de Henares, Madrid

Country

Spain

Phone

+34 691524139

Fax

crisruano95@gmail.com

Contact person for scientific queries

Name

Cristina Ruano Jiménez

Address

University of Alcala de Henares.
Av. de León, 3A, 28805 Alcalá de Henares, Madrid

Country

Spain

Phone

+34 691524139

Fax

crisruano95@gmail.com

Data sharing statement

Will individual participant data (IPD) for this trial be available (including data dictionaries)?

Yes

What data in particular will be shared?

The data of the subjects related to the results of the study, not their personal data.

When will data be available (start and end dates)?

The article will be available indefinitely from its publication.

Available to whom?

The article will be available to everyone looking for studies of this type.

Available for what types of analyses?

The article will be available for different purposes, not just for a specific type of study.

How or where can data be obtained?

The data can be obtained through a web page when the article is published.

What supporting documents are/will be available?

Doc. No.	Type	Citation	Link	Email	Other Details	Attachment
5365	Informed consent form			crisruano95@gmail.com		378571-(Uploaded-22-10-2019-17-24-13)-Study-related document.pdf

Results publications and other study-related documents

Documents added manually

No documents have been uploaded by study researchers.

Documents added automatically

No additional documents have been identified.

Trial Review

Registering a new trial?

Documents added manually

Documents added automatically